Search results for " Polyethylene glycol"

showing 10 items of 40 documents

Mucoadhesive PEGylated inulin-based self-assembling nanoparticles: In vitro and ex vivo transcorneal permeation enhancement of corticosteroids

2019

Abstract As transcorneal drug delivery is still a challenge, the scope of the present study was to prepare useful nanosystems able to enhance transcorneal permeation/penetration of drugs. Moreover, this work aims to evaluate the effectiveness of inulin-based nanosystems in the specific field of ocular drug delivery and the effect of PEG chains to promote mucoadhesion, stability and transcorneal penetration/permeation enhancer effect of self-assembling nanoparticles in vitro (transwell systems and HCE) and ex vivo (Franz cells and bovine cornea). In particular, inulin was chosen as the starting natural polysaccharide polymer to design a novel amphiphilic derivative named INU-EDA-RA-PEG capab…

Polyethylene glycolInulin Self-assembling nanoparticles Transcorneal delivery Retinoic acid Polyethylene glycolTranscorneal deliveryInulinInulinSelf-assembling nanoparticlesPharmaceutical ScienceNanoparticle02 engineering and technologyPenetration (firestop)Permeation021001 nanoscience & nanotechnology030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryAmphiphilePEG ratioRetinoic acidMucoadhesionBiophysics0210 nano-technologyJournal of Drug Delivery Science and Technology
researchProduct

Ionic Hydrogel Based on Chitosan Cross-Linked with 6-Phosphogluconic Trisodium Salt as a Drug Delivery System.

2018

[EN] In this work, 6-phosphogluconic trisodium salt (6-PG(-)Na(+)) is introduced as a new aqueous and nontoxic cross-linking agent to obtain ionic hydrogels. Here, it is shown the formation of hydrogels based on chitosan cross-linked with 6-PG(-)Na(+). This formulation is obtained by ionic interaction of cationic groups of polymer with anionic groups of the cross linker. These hydrogels are nontoxic, do not cause dermal irritation, are easy to extend, and have an adequate adhesion force to be applied as polymeric film over the skin. This AWN formulation exhibits a first order release kinetic and can be applied as drug vehicle for topical administration or as wound dressing for wound healing…

Polymers and PlasticsPolymersAdministration TopicalIonic bondingSalt (chemistry)Bioengineering02 engineering and technology010402 general chemistry01 natural sciencesGluconatesHydrogel Polyethylene Glycol DimethacrylateBiomaterialsChitosanchemistry.chemical_compoundQUIMICA ORGANICADrug Delivery SystemsMaterials ChemistryHumanschemistry.chemical_classificationChitosanWound HealingAqueous solutionWound Closure TechniquesSodiumCationic polymerization021001 nanoscience & nanotechnology0104 chemical sciencesDrug vehicleKineticsCross-Linking ReagentsChemical engineeringchemistrySelf-healing hydrogelsDrug delivery0210 nano-technologyBiomacromolecules
researchProduct

Poly(Ethylene Glycol) Dimethacrylates with Cleavable Ketal Sites: Precursors for Cleavable PEG-Hydrogels.

2017

The authors introduce poly(ethylene glycol) (PEG) based macromonomers containing acid-labile ketal moieties as well as terminal methacrylate units that are amenable to radical polymerization. The synthesis of PEGs of different molecular weights (ranging from 2000 to 13 000 g mol-1 with polydispersities <1.15) with a central ketal unit (PEG-ketal-diol) and their conversion to PEG-ketal-dimethacrylates (PEG-ketal-DMA) is introduced. Degradation rates of both PEG-ketal-diols and PEG-ketal-DMA are investigated by in situ 1 H NMR kinetic studies in deuterated phosphate buffer. Hydrogels containing 0, 5, or 10 wt% of PEG-ketal-DMA and 100, 95, or 90 wt% of PEG-DMA, respectively, are synthesized a…

Polymers and PlasticsRadical polymerizationBioengineeringBiocompatible Materialsmacromolecular substances02 engineering and technology010402 general chemistryMethacrylate01 natural sciencesHydrogel Polyethylene Glycol DimethacrylatePolymerizationBiomaterialschemistry.chemical_compoundPEG ratioPolymer chemistryMaterials ChemistryMolecular massChemistryHydrolysistechnology industry and agricultureHydrogen-Ion Concentration021001 nanoscience & nanotechnology0104 chemical sciencesMolecular WeightKineticsDrug deliverySelf-healing hydrogelsProton NMR0210 nano-technologyEthylene glycolBiotechnologyMacromolecular bioscience
researchProduct

Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency

2014

a b s t r a c t Background: Data on the efficacy of Peg-interferon/ribavirin therapy for chronic hepatitis C are mostly derived from treatment of selected patients enrolled in clinical trials. This study aimed to assess the effectiveness of Peg-interferon/ribavirin therapy in “real world” chronic hepatitis C patients in Italy. Methods: Independent observational multicentre study including consecutive patients receiving Peginterferon/ribavirin in the 18 months before (retrospective phase) and after (prospective phase) the start of the study. Results: 4176 patients were eligible. The final study population consisted of 2051 patients in the retrospective and 2073 in the prospective phase. Sust…

RegistrieMaleCirrhosismedicine.disease_causePolyethylene GlycolGastroenterologyPolyethylene Glycolschemistry.chemical_compoundHepatitis VirusesHepatitis ViruseProspective StudiesViralRegistriesChronicProspective cohort studyDrug CarrierDrug CarriersSettore MED/12 - GastroenterologiaMedicine (all)GastroenterologyRecombinant ProteinMiddle AgedHepatitis CRecombinant ProteinsTreatment OutcomeItalyCombinationRNA ViralPopulation studyDrug Therapy CombinationFemaleHumanmedicine.medical_specialtyGenotypeHepatitis C virusAlpha interferonRibavirin; Sustained virological response (SVR); TreatmentAntiviral AgentsFollow-Up StudieRibavirin; Sustained virological response (SVR); Treatment; Hepatology; GastroenterologyDrug TherapyInternal medicineRibavirinmedicineHumansAntiviral AgentHepatologybusiness.industryRibavirinInterferon-alphaHCV therapyHepatitis C ChronicHepatologymedicine.diseaseClinical trialTreatmentProspective StudiechemistryImmunologyRNARibavirin; Sustained virological response (SVR); Treatment; Antiviral Agents; Drug Carriers; Drug Therapy Combination; Female; Follow-Up Studies; Genotype; Hepatitis C Chronic; Hepatitis Viruses; Humans; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; RNA Viral; Recombinant Proteins; Ribavirin; Treatment Outcome; RegistriesbusinessRibavirin; Sustained virological response (SVR); Treatment; Antiviral Agents; Drug Carriers; Drug Therapy Combination; Female; Follow-Up Studies; Genotype; Hepatitis C Chronic; Hepatitis Viruses; Humans; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; RNA Viral; Recombinant Proteins; Ribavirin; Treatment Outcome; Registries; Gastroenterology; Hepatology; Medicine (all)Follow-Up StudiesSustained virological response (SVR)
researchProduct

Bioactive glass ions induce efficient osteogenic differentiation of human adipose stem cells encapsulated in gellan gum and collagen type I hydrogels

2019

Abstract Background Due to unmet need for bone augmentation, our aim was to promote osteogenic differentiation of human adipose stem cells (hASCs) encapsulated in gellan gum (GG) or collagen type I (COL) hydrogels with bioactive glass (experimental glass 2-06 of composition [wt-%]: Na2O 12.1, K2O 14.0, CaO 19.8, P2O5 2.5, B2O3 1.6, SiO2 50.0) extract based osteogenic medium (BaG OM) for bone construct development. GG hydrogels were crosslinked with spermidine (GG-SPD) or BaG extract (GG-BaG). Methods Mechanical properties of cell-free GG-SPD, GG-BaG, and COL hydrogels were tested in osteogenic medium (OM) or BaG OM at 0, 14, and 21 d. Hydrogel embedded hASCs were cultured in OM or BaG OM fo…

SerumAdipose stem cellCompressive StrengthAdipose tissueCell Count02 engineering and technologySpectrum Analysis Raman01 natural sciencesMineralization (biology)Hydrogel Polyethylene Glycol Dimethacrylatelaw.inventionchemistry.chemical_compoundOsteogenesislawOsteogenic differentiationBioactive glassMineralsTissue ScaffoldsbiologyStem CellsPolysaccharides Bacterialbioactive glassCell DifferentiationMiddle Aged021001 nanoscience & nanotechnologyGellan gumCross-Linking ReagentsAdipose TissueMechanics of MaterialsBioactive glassSelf-healing hydrogelsOsteocalcinFemaleStem cellimplantit0210 nano-technologyMaterials scienceCell SurvivalOsteocalcinosteogenic differentiationchemistry.chemical_elementBioengineeringmacromolecular substancesCalciumta3111010402 general chemistryCollagen Type ICollagen type I hydrogelBiokemia solu- ja molekyylibiologia - Biochemistry cell and molecular biologylasiBiomaterialsCalcification Physiologicbiologinen aktiivisuusgellan gum hydrogelAnimalsHumansta217Ionsgeelitta1182adipose stem cellkantasolutRats0104 chemical sciencesDurapatiteGene Expression RegulationchemistryBiophysicsbiology.proteinGlassGellan gum hydrogelluukudoksetcollagen type I hydrogelBiomarkersMaterials Science and Engineering: C
researchProduct

Surface AFM microscopy of unworn and worn samples of silicone hydrogel contact lenses

2008

Abstract: Purpose. To evaluate the qualitative and quantitative topographic changes in the surface of worn contact lenses (CLs) of different materials using atomic force microscopy (AFM). Methods. The topography of five different CL materials was evaluated withAFM over a surface of 25 lm2 according to previously published experimental setup. Average roughness (Ra) and root mean square (Rms) values were obtained for unworn and worn samples. Results. The Ra value increased for balafilcon A (11.62–13.68 nm for unworn and worn samples, respectively), lotrafilcon A (3.67–15.01 nm for unworn and worn samples, respectively), lotrafilcon B (4.08–8.42 nm for unworn and worn samples, respectively), g…

SiliconSurface characterizationwearMaterials scienceContact LensesSurface PropertiesSiliconesBiomedical Engineering02 engineering and technologySurface finishMicroscopy Atomic ForceHydrogel Polyethylene Glycol DimethacrylateBiomaterialsAtomic force microscopyPolymer deterioration03 medical and health sciences0302 clinical medicineOpticsMaterials TestingMicroscopySurface roughnessComposite materialdegradationScience & TechnologyAtomic force microscopybusiness.industryHydrogelsLotrafilcon BContact lensSilicone hydrogelContact Lenses Hydrophilic021001 nanoscience & nanotechnologyContact lensPseudomonas aeruginosaWettability030221 ophthalmology & optometryWetting0210 nano-technologybusinessJournal of Biomedical Materials Research Part B: Applied Biomaterials
researchProduct

Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women

2014

AIM: To investigate the safety/efficacy of Boceprevirbased triple therapy in hepatitis C virus (HCV)-G1 menopausal women who were historic relapsers, partial-responders and null-responders. METHODS: In this single-assignment, unblinded study, we treated fifty-six menopausal women with HCV-G1, 46% F3-F4, and previous PEG-α/RBV failure (7% null, 41% non-responder, and 52% relapser) with 4 wk lead-in with PEG-IFNα2b/RBV followed by PEGIFNα2b/RBV+Boceprevir for 32 wk, with an additional 12 wk of PEG-IFN-α-2b/RBV if patients were HCV-RNA-positive by week 8. In previous null-responders, 44 wk of triple therapy was used. The primary objective of retreatment was to verify whether a sustained virolo…

Time FactorsViral HepatitisClinical Trials StudyHepacivirusViral hepatitiPolyethylene GlycolPolyethylene Glycolschemistry.chemical_compoundPegylated interferonOdds RatioMultivariate AnalysiPegylated InterferonGastroenterologyGeneral MedicineHepatitis CHepatitis c virus treatmentMiddle AgedRecombinant ProteinViral LoadGenotype 1Recombinant ProteinsMenopauseTreatment OutcomeItalyRNA ViralDrug Therapy CombinationFemaleMenopauseViral hepatitisViral loadPegylated interferonHumanmedicine.drugmedicine.medical_specialtyGenotypeLogistic ModelProlineTime FactorInterferon alpha-2Hepatitis C virus treatmentAntiviral AgentsPharmacotherapyInternal medicineBoceprevirRibavirinmental disordersmedicineHumansAntiviral AgentHepacivirubusiness.industryInterferon-alphaBiomarkerGenotype 1; Hepatitis c virus treatment; Menopause; Pegylated interferon; Viral hepatitis; Antiviral Agents; Biomarkers; Drug Therapy Combination; Female; Genotype; Hepacivirus; Hepatitis C Chronic; Humans; Interferon-alpha; Italy; Logistic Models; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Proline; RNA Viral; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome; Viral Load; Menopause; GastroenterologyHepatitis C Chronicmedicine.diseaseVirologyLogistic ModelschemistryHepatitis C Virus PositiveMultivariate AnalysisGenotype 1; Hepatitis C virus treatment; Menopause; Pegylated Interferon; Viral HepatitisbusinessBiomarkers
researchProduct

Engineering a morphogenetically active hydrogel for bioprinting of bioartificial tissue derived from human osteoblast-like SaOS-2 cells.

2014

Abstract Sodium alginate hydrogel, stabilized with gelatin, is a suitable, biologically inert matrix that can be used for encapsulating and 3D bioprinting of bone-related SaOS-2 cells. However, the cells, embedded in this matrix, remain in a non-proliferating state. Here we show that addition of an overlay onto the bioprinted alginate/gelatine/SaOS-2 cell scaffold, consisting of agarose and the calcium salt of polyphosphate [polyP·Ca 2+ -complex], resulted in a marked increase in cell proliferation . In the presence of 100 μ m polyP·Ca2+ -complex, the cells proliferate with a generation time of approximately 47–55 h. In addition, the hardness of the alginate/gelatin hydrogel substantially i…

food.ingredientMaterials scienceAlginatesBiophysicschemistry.chemical_elementBioengineeringBiocompatible MaterialsCalciumGelatinHydrogel Polyethylene Glycol Dimethacrylatelaw.inventionCell LineBiomaterialschemistry.chemical_compoundfoodTissue engineeringGlucuronic AcidlawHardnessPolyphosphatesElastic ModulusmedicineHumansSaos-2 cellsCell Proliferation3D bioprintingOsteoblastsTissue EngineeringTissue ScaffoldsPolyphosphateHexuronic AcidsBioprintingOsteoblastmedicine.anatomical_structurechemistryMechanics of MaterialsCeramics and CompositesBiophysicsAgaroseGelatinBiomedical engineeringBiomaterials
researchProduct

New hydrogel matrices containing an anti-inflammatory agent. Evaluation of in vitro release and photoprotective activity.

2002

In the present work. the preparation and characterization of hydrogels based on alpha,beta-polyaspartylhydrazide (PAHy) chemically crosslinked with ethyleneglycol diglycidylether (EGDGE) containing Tolmetin sodium salt, are reported. In particular, these samples have been prepared both as water swellable microparticles and as gels at two different crosslinking degrees. The incorporation of Tolmetin sodium salt in PAHy-EGDGE microparticles has been performed after the crosslinking reaction by a soaking procedure or during the formation of the network. The influence of drug loading procedure on Tolmetin release has been evaluated by performing in vitro release study in simulated gastrointesti…

medicine.drug_classPhotochemistrySodiumBiophysicsSynthetic membranechemistry.chemical_elementSalt (chemistry)BioengineeringIn Vitro TechniquesCrystallography X-RayAnti-inflammatoryHydrogel Polyethylene Glycol DimethacrylateBiomaterialsmedicineOrganic chemistryTolmetinchemistry.chemical_classificationChromatographyAnti-Inflammatory Agents Non-Steroidalmedicine.diseaseIn vitroHemolysischemistryMechanics of MaterialsSelf-healing hydrogelsCeramics and CompositesTolmetinmedicine.drugBiomaterials
researchProduct

CpG-Loaded Multifunctional Cationic Nanohydrogel Particles as Self-Adjuvanting Glycopeptide Antitumor Vaccines

2014

Self-adjuvanting antitumor vaccines by multifunctional cationic nanohydrogels loaded with CpG. A conjugate consisting of tumor-associated MUC1-glycopeptide B-cell epitope and tetanus toxin T-cell epitope P2 is linked to cationic nanogels. Oligonucleotide CpG complexation enhances toll-like receptor (TLR) stimulated T-cell proliferation and rapid immune activation. This co-delivery promotes induction of specific MUC1-antibodies binding to human breast tumor cells without external adjuvant.

medicine.medical_treatmentMolecular Sequence DataBiomedical EngineeringPharmaceutical ScienceEnzyme-Linked Immunosorbent Assaymedicine.disease_causeCancer VaccinesHydrogel Polyethylene Glycol DimethacrylateEpitopeBiomaterialsAdjuvants ImmunologicCationsmedicineAnimalsHumansAmino Acid SequenceReceptorMice Inbred BALB COligonucleotideToxinChemistryGlycopeptidesGlycopeptideOligodeoxyribonucleotidesCpG siteImmunologyCancer researchNanoparticlesAdjuvantConjugateAdvanced Healthcare Materials
researchProduct